The words you are searching are inside this book. To get more targeted content, please make full-text search by clicking here.

According to the latest research report by IMARC Group, The global alopecia treatment market size reached US$ 3.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.8 Billion by 2032, exhibiting a growth rate (CAGR) of 4.1% during 2024-2032.

More Info:- https://www.imarcgroup.com/alopecia-treatment-market

Discover the best professional documents and content resources in AnyFlip Document Base.
Search
Published by minirana001, 2024-04-10 10:32:14

Alopecia Treatment Market PDF 2024: Industry Trends, Share, Size, Demand and Future Scope by 2032

According to the latest research report by IMARC Group, The global alopecia treatment market size reached US$ 3.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.8 Billion by 2032, exhibiting a growth rate (CAGR) of 4.1% during 2024-2032.

More Info:- https://www.imarcgroup.com/alopecia-treatment-market

Global Alopecia Treatment Market Research and Forecast Report 2024-2032 Format: PDF+EXCEL © 2023 IMARC All Rights Reserved


About IMARC Group International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all regions and industry verticals to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the c ompan y’s expertise. IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.


Report Highlight and Description According to the latest report by IMARC Group, titled "Alopecia Treatment Market: Global Industry Trends, Share, Size, Grow th, Opportunity and Forecast 2024-2032," the global alopecia treatment market size reached US$ 3.3 Billion in 2023. Alopecia is a medical condition characterized by hair loss, which can occur on the scalp or other parts of the body. It is caused due to several factors, including a sedentary lifestyle, unhealthy eating habits, and growing stress levels . Its treatment is dependent on numerous factors, such as the type of alopecia areata, patient age, and the extent of hair loss . The treatment aims to block the immune system attack and stimulate the regrowth of hair. Various drugs and surgical treatment options, including hair transplantation and scalp reduction, have been widely adopted for the treatment of alopecia. Besides, medications including minoxidil or finasteride are also used for baldness . These medications are formulated to stimulate hair growth or prevent further hair loss. Besides, phototherapy or low light laser therapy (LLLT) is gaining traction around the world as it is safer, tolerable, and less invasive than other treatments . Request for a PDF sample of this report: https://www.imarcgroup.com/alopecia -treatment-market/requestsample


Report Description Global Alopecia Treatment Market Trends: The incre as ing preva le n ce of alo pec ia amo ng the masse s is dr iving the g lo b a l mark et . Cou p le d wit h this, the ris ing cas es of po lyc yst ic o var y s yndrom e (PCOS) are c ontr ib ut ing to th e o vera ll g ro wth of th e mark et . In lin e wit h th is, stre ssf u l lif est yles, the esc alat ing c ase s of ma ln utr itio n, an d the ris ing numb er of in divid u a ls wit h c erta in m ed ica l co n d it ion s, su ch as diabetes, lupus, and pers istent we ig ht loss, are catalyzing the increas ing risk of hair loss . Moreover, the growing a wa re n ess a bo ut ha ir los s an d the ava ila b ilit y of var iou s treatment opt ion s is impa ct ing the mark et f avorab ly . Be s ide s, th e a va ilab ilit y of a d van ce d treatment opt ions, in c lud ing p late let-r ic h p lasma (PRP) ther ap y, mes othera p y, an d lo w-le ve l la s er thera p y (L LLT)are act ing a s anot her g ro wt h-in du c ing f actor. Alo ng with th is, th e in crea sing a va ilab ilit y of pr od ucts, in c lu d ing s hamp oos, co nd it io ners, and other h a ir care pro du cts that cla im to pre ve nt ha ir loss and promote h a ir g ro wt h is a ls o contr ib ut ing to the g ro wth of the a lo pec ia treatment mark et . Ad d it ion a lly, the introd uct io n of las er caps, he lm ets, c ombs, a nd ba nd s ar e inf lue nc ing the mark et . Furth ermore, s e ver a l k e y p la yers are h ea vily in ve sting in re se arc h a nd d e ve lopme nt act ivit ie s to d e ve lo p n ove l treatment o pt io ns, thu s pro vid ing a b oo st to the mark et . Ap art from th is, the in cre as ing a va ila b ilit y of ad van ce d tre atment opt io ns suc h as stem ce ll ther ap y a nd g en e ther ap y is cre ating a pos it ive mark et out lo ok . The mark et is f urther dr ive n b y other f actors, s uch as the in cre as ing a va ila b ilit y of ad van ce d treatment o pt io ns, c ont in u ous im pro vements in h e a lthc are inf rastru cture, a nd incre as ing co nc erns among p are nts ab o ut th e h ea lt h o f t h e ir c h ild r e n. Looking forw ard, the market is anticipated to reach a value of US$ 4.8 Billion by 2032, exhibiting a grow th rate (CAGR) of 4.1% during 2024-2032. View Report TOC, Figures and Tables: https://www.imarcgroup.com/alopecia-treatment-market


Report Segmentation B reakup by D r ug Type: • Min oxid i l • F in a ster i d e • O thers B reakup by Indication: • An d roge n i c Alop ec ia • Alop ec ia Areata • Alop ec ia Tota lis • O th ers B reakup by G ender: • Ma le • Fema le B reakup by Route of Administration: • O ral


Report Segmentation • Top ica l • In jec ta b l e B reakup by D ist r ibution Channel: • Hosp ita l s • Reta il Ph a r ma c ie s • O nline Pharmacie s B reakup by Region: • Nor th Amer ica • Asia-Pac i fi c • E u rop e • Latin Amer ica • Mid d le Ea st a n d Afr ica


Competitive Landscape with Key Players • Aclaris Therapeutics Inc. • Cellmid Limited • Cipla Limited • Dr. Reddy ’s Labo ratories Ltd. • Glaxo SmithKline plc • HCell Inc. • Jo hnso n & Jo hnso n • Merck & Co . Inc. • P f izer Inc. • Taisho Pharmaceutical Ho ldings Co . Ltd • Teva Pharmaceutical Industries Ltd.


Key Questions Answered in the Report What was the size of the global alopecia treatment market in 2023? What is the expected growth rate of the global alopecia treatment market during 2024-2032? What are the key factors driving the global alopecia treatment market? What has been the impact of COVID-19 on the global alopecia treatment market? What is the breakup of the global alopecia treatment market based on the drug type? What is the breakup of the global alopecia treatment market based on the indication? What is the breakup of the global alopecia treatment market based on gender?


Key Questions Answered in the Report What is the breakup of the global alopecia treatment market based on the route of administration? What is the breakup of the global alopecia treatment market based on the distribution channel? What are the key regions in the global alopecia treatment market? Who are the key players/companies in the global alopecia treatment market?


Table of Contents 1 Pr e fac e 2 Sc ope a nd M e t hodology 2. 1 O bj ectives of t he St udy 2 . 2 St ak eh o lde rs 2 . 3 Da t a So u r c es 2 . 3.1 Pr imary So u r c e s 2 . 3.2 Se c o n dary So u r c e s 2 . 4 Ma r k et Es t im atio n 2 . 4.1 Bo ttom -Up Ap p r o a ch 2 . 4.2 T o p-Do wn Ap p r o a ch 2 . 5 Fo r eca sting Me t h o d o log y 3 Executive Sum m ary 4 I ntroduction 4 . 1 O vervie w 4 . 2 Ke y I n d u stry T r e n d s 5 Global Al ope c i a Tr e a t me nt M a r ke t 5 . 1 Ma r k et O ve r vie w 5 . 2 Ma r k et Pe r f orman ce 5 . 3 I mpa ct o f CO VI D-1 9 5 . 4 Ma r k et Fo r e c a st 6 M a r k et Br e a k up by Dr ug Type 6 . 1 Min o xid il 6 . 1.1 Ma r k et T r e nd s 6 . 1.2 Ma r k et Fo r e c ast 6 . 2 Fin a s terid e 6 . 2.1 Ma r k et T r e nd s 6 . 2.2 Ma r k et Fo r e c ast 6 . 3 Oth ers 6 . 3.1 Ma r k et T r e nd s 6 . 3.2 Ma r k et Fo r e c ast 7 Mar k et Br eak up by I ndic ation


Table of Contents 7 . 1 An d rog e nic Alo p e c ia 7 . 1.1 Ma r k et T r e nd s 7 . 1.2 Ma r k et Fo r e c ast 7 . 2 A lo p e c ia A r e a ta 7 . 2.1 Ma r k et T r e nd s 7 . 2.2 Ma r k et Fo r e c ast 7 . 3 A lo p e c ia T o t a lis 7 . 3.1 Ma r k et T r e nd s 7 . 3.2 Ma r k et Fo r e c ast 7 . 4 Oth ers 7 . 4.1 Ma r k et T r e nd s 7 . 4.2 Ma r k et Fo r e c ast 8 M a r k et Br e a k up by G e nde r 8 . 1 Ma le 8. 1.1 Mar k et T r ends 8 . 1.2 Ma r k et Fo r e c ast 8 . 2 F e ma le 8 . 2.1 Ma r k et T r e nd s 8 . 2.2 Ma r k et Fo r e c ast 9 M a r k et Br e a k up by Rout e of Adm i ni s t ration 9 . 1 O ral 9 . 1.1 Ma r k et T r e nd s 9 . 1.2 Ma r k et Fo r e c ast 9 . 2 T o pic a l 9 . 2.1 Ma r k et T r e nd s 9 . 2.2 Ma r k et Fo r e c ast 9 . 3 I n jecta ble 9 . 3.1 Ma r k et T r e nd s 9 . 3.2 Ma r k et Fo r e c ast For m or e i nf ormation, vi s i t: h t t p s : / / w w w . i m a r c g r o u p . c o m / a l o p e c i a -t r e a t m e n t-m a r k e t / t o c


Disclaimer © 2023 IMARC All Rights Reserved This Publication and all it’ s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies .


Contact Us Visit us at : https://www.imarcgroup.com TELEPHONE: +1-631-791-1145 E-MAIL: [email protected]


Click to View FlipBook Version